Results
|
821.
|
|
|
822.
|
|
|
823.
|
Benzylidene-indolinones are effective as multi-targeted kinase inhibitor therapeutics against hepatocellular carcinoma. [electronic resource] by
- Ho, Han Kiat
- Chua, Boon Tin
- Wong, Winnie
- Lim, Kah Suan
- Teo, Vivian
- Ong, Hooi-Tin
- Chen, Xiao
- Zhang, Wei
- Hui, Kam M
- Go, Mei Lin
- Ullrich, Axel
Producer: 20150623
In:
Molecular oncology vol. 8
Availability: No items available.
|
|
824.
|
|
|
825.
|
Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells. [electronic resource] by
- Paulus, A
- Akhtar, S
- Caulfield, T R
- Samuel, K
- Yousaf, H
- Bashir, Y
- Paulus, S M
- Tran, D
- Hudec, R
- Cogen, D
- Jiang, J
- Edenfield, B
- Novak, A
- Ansell, S M
- Witzig, T
- Martin, P
- Coleman, M
- Roy, V
- Ailawadhi, S
- Chitta, K
- Linder, S
- Chanan-Khan, A
Producer: 20171103
In:
Blood cancer journal vol. 6
Availability: No items available.
|
|
826.
|
|
|
827.
|
|
|
828.
|
|
|
829.
|
|
|
830.
|
|
|
831.
|
EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma. [electronic resource] by
- Yin, Da-Long
- Liang, Ying-Jian
- Zheng, Tong-Sen
- Song, Rui-Peng
- Wang, Jia-Bei
- Sun, Bo-Shi
- Pan, Shang-Ha
- Qu, Lian-Dong
- Liu, Jia-Ren
- Jiang, Hong-Chi
- Liu, Lian-Xin
Producer: 20180516
In:
Scientific reports vol. 6
Availability: No items available.
|
|
832.
|
|
|
833.
|
|
|
834.
|
Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes. [electronic resource] by
- Yasmin, Sabina
- Capone, Fabio
- Laghezza, Antonio
- Piaz, Fabrizio Dal
- Loiodice, Fulvio
- Vijayan, Viswanathan
- Devadasan, Velmurugan
- Mondal, Susanta K
- Atlı, Özlem
- Baysal, Merve
- Pattnaik, Ashok K
- Jayaprakash, Venkatesan
- Lavecchia, Antonio
Producer: 20190701
In:
Scientific reports vol. 7
Availability: No items available.
|
|
835.
|
|
|
836.
|
|
|
837.
|
|
|
838.
|
|
|
839.
|
|
|
840.
|
|